查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017171

植入市場：依產品類型、材料、最終用戶和通路分類－2026-2032年全球市場預測

Bio-implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，植入市場價值將達到 1,432.1 億美元，到 2026 年將成長至 1,527.9 億美元，到 2032 年將達到 2,453.2 億美元，複合年成長率為 7.99%。

主要市場統計數據
基準年 2025 1432.1億美元
預計年份：2026年 1527.9億美元
預測年份 2032 2453.2億美元
複合年成長率 (%) 7.99%

策略性介紹：植入創新、監管演變、臨床需求和商業化重點在當今醫療保健生態系統中的地位

本執行摘要概述了技術創新、不斷變化的監管環境和醫療模式的轉變交織而成的複雜格局，為植入的相關人員帶來了新的機會和營運挑戰。新型器材結構和材料科學的進步正在重新定義器材的性能和耐久性，而日益重視以價值為導向的醫療模式也對臨床療效的衡量和成本透明度提出了新的要求。同時，臨床醫生、工程師和保險公司之間的跨學科合作正在加速將有前景的概念從研究轉化為臨床實踐。

概述了正在重新定義植入開發商如何向患者和醫療保健提供者提供治療方法的關鍵技術、監管和醫療模式轉變。

植入領域正經歷一場變革，這場變革是由技術、政策和臨床實踐三者協同作用所推動的。生物材料的進步和器械的微型化使得微創手術成為可能，並延長了器械的使用壽命，從而改變了醫保報銷的討論和臨床路徑。同時，遠端監測和遠端追蹤等數位醫療技術的引入正在重塑術後護理，並為植入與患者數據生態系統的整合創造了機會。

分析 2025 年價格調整對整個植入產業的供應鏈、採購決策和製造韌性的實際和策略影響。

2025年實施的關稅措施對製造商、供應商和醫療保健機構產生了多方面的影響，遠不止表面上的成本調整。關稅變化凸顯了在地化生產策略和供應商多元化對於降低跨境貿易中斷風險的重要性。對於依賴國際採購的企業而言，最直接的影響是加速近岸外包，並評估替代材料供應商，以在確保產品品質的同時，盡可能減少利潤率的下降。

將產品類型、材料、最終用戶和分銷管道與可操作的商業化和研發重點連結起來的詳細細分見解。

捕捉細分市場的細微差別，可以揭示臨床需求如何與材料和分銷行為相互交織，以及這些交織關係應​​如何在產品組合策略中體現。根據產品類型，市場包括心血管植入（例如人工心臟瓣膜、心律調節器、支架和血管移植物）；人工植牙（例如骨內植入物、骨膜下植入物和經骨植入物）；神經系統植入（例如深部腦刺激器、義肢和脊髓刺激設備） ；整形外科植入植入（例如角膜植入、人工水晶體和關節植入物）、以及關節植入物）。髖植入進一步分為髖關節表面置換術和全髖關節置換術，膝關節植入物分為部分膝關節關節重建和全膝關節置換術。這些產品區分反映了不同的臨床工作流程、報銷途徑和外科醫生培訓要求，每種情況都需要量身定做的證據生成和市場進入策略。

主要區域趨勢和差異化策略，使全球主要市場的監管環境、臨床實踐和採購行為保持一致。

區域趨勢透過不同的管理體制、支付方環境和臨床基礎設施，創造出競爭優勢，因此，基於地理的策略對於有效進入和拓展市場至關重要。在美洲，與公立和私立支付方的緊密合作，以及先進的外科手術網路，正在推動高價值植入的快速普及，同時也要求提供關於成本效益和長期療效的嚴格證據。同時，歐洲、中東和非洲（EMEA）呈現出多元化的環境，監管協調的努力與各國特有的報銷體系並存，這需要靈活的市場進入計劃和本地夥伴關係關係，以確保處方集納入和臨床醫生的支持。

深入了解利用產品平台、臨床夥伴關係和供應鏈韌性來創造可衡量的差異化和商業性優勢的競爭行為。

植入領域的主要企業正透過技術差異化、臨床夥伴關係和營運規範相結合，建立競爭優勢。成功的企業正投資開發模組化平台，以縮短不同產品的上市時間，並利用與領先臨床中心的合作，產生可靠的真實世界數據（REW）。這些企業還優先考慮材料科學領域的創新，將先進的聚合物、陶瓷和鈦合金與表面處理相結合，以提高生物相容性並降低重新置換率，從而增強其對臨床機構和支付方的說服力。

為經營團隊提供可操作的建議，結合產品平台策略、證據產生、供應鏈韌性和有針對性的市場進入舉措，以取得可衡量的結果。

領導者應採取平衡策略，透過有針對性的投資和切實可行的營運改革，在加速創新的同時降低市場風險。首先，應優先考慮模組化產品平台和注重可製造性的設計，以確保零件可互換，並加快監管核准流程。同時，應投資於嚴謹的真實世界數據項目和系統的上市後監測，以驗證長期療效，並為與保險公司的談判提供支援。這些資料收集工作必須與臨床合作夥伴合作進行，以確保其有效性和適用性。

對嚴謹的多方法研究途徑、與關鍵相關人員的訪談以及用於產生可靠和可操作見解的分析方法進行了清晰的解釋。

本報告採用多維度的研究方法，結合一手質性訪談、二手文獻整合和個案比較分析，以確保分析的嚴謹性和實用性。一手研究包括對臨床醫生、採購經理、監管觀點和醫療設備工程師進行結構化訪談，以了解不同相關人員對臨床效用、推廣障礙和採購標準的看法。這些訪談結果與同行評審的臨床研究、監管文件和公開政策文件等二級資訊來源進行交叉比對，以檢驗趨勢並支持技術論點。

整合簡潔的結論，以支持將技術進步轉化為臨床應用和永續商業性成功的策略重點。

總而言之，植入市場正處於技術快速發展與營運日益複雜化的交匯點，因此需要一種融合創新與實際執行的綜合策略。能夠將平台設計、材料專業知識和可靠的真實世界證據與穩健的供應鏈和針對特定區域的市場進入計劃相結合的相關人員，最有能力將科學進步轉化為永續的商業性成功。此外，不斷變化的關稅和法規環境凸顯了靈活的生產和籌資策略的重要性，這些策略既要保護利潤率，又要確保臨床品質。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：植入市場：依產品類型分類

  • 心血管植入
    • 人工心臟瓣膜
    • 心律調節器
    • 支架
    • 血管移植
  • 人工植牙
    • 骨內植入
    • 骨膜下植入
    • 骨內植入
  • 神經系統植入
    • 深層腦部刺激器
    • 神經義肢
    • 脊髓刺激設備
  • 眼科植入
    • 角膜植入
    • 人工水晶體
    • 視網膜植入
  • 整形外科植入
    • 髖關節植入
      • 髖關節表面置換術
      • 全髖關節置換術
    • 膝關節植入
      • 部分膝關節關節重建手術
      • 全膝關節置換術
    • 肩關節關節移植
    • 脊椎移植

第9章：植入市場：依材料分類

  • 陶瓷製品
  • 複合材料
  • 聚合物
    • 可生物分解聚合物
    • UHMWPE
  • 鈦

第10章：植入市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
  • 研究機構

第11章：植入市場：依通路分類

  • 離線
  • 線上

第12章：植入市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：植入市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：植入市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國植入市場

第16章：中國植入市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • BioHorizons
  • Dentsply Sirona Inc
  • HIOSSEN
  • Institut Straumann AG
  • MEGA'GEN IMPLANT CO.,LTD.
  • Nobel Biocare Services AG
  • NuVasive, Inc.
  • OSSTEM IMPLANT CO., LTD.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc
Product Code: MRR-0355054AC501

The Bio-implant Market was valued at USD 143.21 billion in 2025 and is projected to grow to USD 152.79 billion in 2026, with a CAGR of 7.99%, reaching USD 245.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 143.21 billion
Estimated Year [2026] USD 152.79 billion
Forecast Year [2032] USD 245.32 billion
CAGR (%) 7.99%

A strategic introduction that positions bio-implant innovation, regulatory evolution, clinical demand, and commercialization priorities within today's healthcare ecosystem

This executive summary frames a complex environment where technological innovation, regulatory evolution, and shifting care models converge to create new opportunities and operational challenges for bio-implant stakeholders. Emerging device architectures and material science advances are redefining device performance and durability, while the growing emphasis on value-based care places new demands on clinical outcome measurement and cost transparency. Meanwhile, cross-discipline collaboration between clinicians, engineers, and payers is increasing the rate at which promising concepts move from bench to bedside.

Against this backdrop, executives must reconcile strategic imperatives-such as faster innovation cycles, supply chain resilience, and payer engagement-with tactical priorities like implant selection, surgical training, and post-market surveillance. Effective strategies will therefore balance investment in differentiated technologies with practical approaches to regulatory compliance, clinician adoption, and distribution agility. In doing so, organizations can strengthen their position within healthcare ecosystems and deliver measurable patient benefits while managing clinical, financial, and operational risk.

An overview of the major technological, regulatory, and care model shifts that are redefining how bio-implant developers bring therapies to patients and providers

The landscape for bio-implants is undergoing transformative shifts driven by converging forces across technology, policy, and clinical practice. Advances in biomaterials and device miniaturization are enabling less invasive procedures and extending device longevity, which in turn alters reimbursement conversations and clinical pathways. Concurrently, the adoption of digital health adjuncts such as remote monitoring and tele-follow up is reshaping post-operative care, creating opportunities for implants that integrate with patient data ecosystems.

Regulatory frameworks are also moving toward increased emphasis on real-world evidence and continuous safety monitoring, which raises the bar for manufacturers to demonstrate longitudinal performance and patient-centered outcomes. Supply chain reconfiguration and a focus on regional resilience are prompting firms to diversify sourcing and manufacturing footprints. Taken together, these shifts require companies to adopt nimble commercialization models that prioritize clinical validation, data interoperability, and collaborative partnerships to capture emerging demand and sustain long-term growth.

An analysis of the practical and strategic consequences of the 2025 tariff landscape on supply chains, procurement decisions, and manufacturing resilience across the bio-implant sector

The tariff actions introduced in 2025 have created a layered set of implications for manufacturers, suppliers, and healthcare providers that extend beyond headline cost adjustments. Tariff changes have increased the importance of localized production strategies and supplier diversification to mitigate exposure to cross-border trade disruptions. For organizations reliant on international sourcing, the immediate effect has been an acceleration of nearshoring initiatives and an evaluation of alternate material suppliers to preserve device quality while limiting margin erosion.

Furthermore, procurement teams within hospitals and ambulatory surgical centers have begun to re-assess vendor contracts and total cost of ownership, weighing increased landed costs against clinical performance metrics. In response, manufacturers have prioritized transparent cost models, modular product designs that allow component substitution, and strategic inventory management to maintain continuity of supply. Over time, these adaptations are influencing contractual dynamics, shaping supplier selection criteria, and prompting renewed emphasis on manufacturing flexibility and regulatory harmonization to sustain global market access.

In-depth segmentation insights that connect product categories, material choices, clinical end users, and distribution channels to practical commercialization and R&D priorities

A nuanced view of segmentation reveals where clinical demand intersects with material science and distribution behaviors, and how those intersections should inform portfolio strategy. Based on product type, the market spans cardiovascular implants including artificial heart valves, pacemakers, stents, and vascular grafts; dental implants such as endosseous, subperiosteal, and transosteal systems; neurological implants including deep brain stimulators, neuroprosthetics, and spinal cord stimulators; ophthalmic implants encompassing corneal substitutes, intraocular lenses, and retinal devices; and orthopedic implants with hip, knee, shoulder, and spinal options, where hip devices further differentiate into hip resurfacing and total hip replacement and knee solutions distinguish partial knee replacement from total knee replacement. These product distinctions reflect divergent clinical workflows, reimbursement pathways, and surgeon training requirements, and they necessitate tailored evidence generation and go-to-market approaches.

Turning to material segmentation, key categories include ceramic, composite, polymer, and titanium, with polymers subdivided into biodegradable polymers and ultra-high molecular weight polyethylene variants. Material choice has direct implications for device longevity, biocompatibility, sterilization protocols, and regulatory dossiers, and therefore must align with clinical endpoints and manufacturing capabilities. From an end-user perspective, the distribution of demand across ambulatory surgical centers, clinics, hospitals, and research institutes indicates differing purchasing cycles, tender processes, and clinical adoption timelines; each end-user type presents unique requirements for packaging, training, and post-sales support.

Finally, channel dynamics hinge on the coexistence of offline and online distribution models. Offline channels remain dominant for high-complexity devices requiring clinical demonstrations and sterile logistics, while online channels are gradually expanding for ancillary components, consumables, and information dissemination. Strategic segmentation analysis should therefore integrate product complexity, material constraints, end-user procurement behavior, and channel suitability to prioritize investments and operational focus.

Key regional dynamics and differentiated strategies that align regulatory landscapes, clinical practices, and procurement behaviors across major global markets

Regional dynamics are shaping competitive advantage through differing regulatory regimes, payer landscapes, and clinical infrastructures, and a geographically informed strategy is essential for effective market entry and expansion. In the Americas, strong private and public payer engagement combined with advanced surgical networks fosters rapid adoption of high-value implants, but it also demands rigorous evidence of cost effectiveness and longitudinal performance. Meanwhile, Europe, Middle East & Africa presents a heterogeneous environment in which regulatory harmonization efforts coexist with country-level reimbursement idiosyncrasies, requiring nimble market access planning and local partnerships to secure formulary placement and clinician endorsement.

In Asia-Pacific, a combination of high surgical volumes, growing healthcare investment, and favorable manufacturing ecosystems creates significant opportunities for scale, yet success depends on adapting products to local clinical practices and price sensitivity. Across these regions, differences in clinical training standards, procurement cycles, and hospital infrastructure necessitate region-specific clinical evidence packages, pricing strategies, and supply chain configurations. Therefore, thoughtful regional prioritization and tailored engagement models will accelerate adoption while reducing execution risk.

Insights into competitive behaviors where product platform thinking, clinical partnership, and supply chain resilience create measurable differentiation and commercial advantage

Leading companies in the bio-implant arena are demonstrating a mix of technology differentiation, clinical partnership, and operational discipline that defines competitive positioning. Successful organizations are investing in modular platform development to reduce time to market for variant devices and leveraging partnerships with leading clinical centers to generate robust real-world evidence. These firms also prioritize materials science innovation-combining advanced polymers, ceramics, and titanium alloys with surface treatments-to improve biocompatibility and reduce revision rates, thereby strengthening clinical and payer narratives.

Operationally, top performers are building resilient supply chains through multi-sourcing, regional manufacturing footprints, and digital traceability solutions to meet regulatory expectations and manage tariff exposure. In addition, companies that have integrated digital health capabilities around implantable devices-such as remote monitoring and data analytics-are creating differentiated propositions that support outcomes-based contracting and enhanced post-market surveillance. As a result, competitive advantage increasingly accrues to firms that combine clinical credibility, material and design innovation, and adaptable commercial models.

Actionable recommendations for leadership that combine product platform strategy, evidence generation, supply chain resilience, and targeted market access initiatives for measurable impact

Leaders should pursue a balanced agenda that accelerates innovation while de-risking commercialization through targeted investments and pragmatic operational changes. First, prioritize modular product platforms and design for manufacturability to enable component substitution and faster regulatory pathways. In parallel, invest in rigorous real-world evidence programs and structured post-market studies that demonstrate long-term outcomes and support payer negotiations. These data initiatives should be coordinated with clinical partners to ensure relevance and adoption.

Second, strengthen supply chain resilience by diversifying suppliers, evaluating near-shoring opportunities, and implementing digital traceability systems to improve inventory visibility and compliance. Third, tailor market access strategies to regional and end-user realities by aligning pricing, clinical evidence, and training programs with the specific needs of hospitals, ambulatory surgical centers, clinics, and research institutes. Finally, embrace digital adjuncts such as remote monitoring and patient engagement tools to enhance the value proposition of implants and facilitate outcome-driven contracting. Together, these actions will help organizations capture clinical trust, reduce operational risk, and unlock sustainable revenue pathways.

A clear description of the rigorous multi-method research approach, primary stakeholder interviews, and analytical techniques used to produce reliable and actionable insights

This report synthesizes a multi-method research approach combining primary qualitative interviews, secondary literature synthesis, and comparative case analysis to ensure analytical rigor and practical relevance. Primary research included structured interviews with clinicians, procurement leaders, regulatory specialists, and device engineers to capture diverse stakeholder perspectives on clinical utility, adoption barriers, and purchasing criteria. These insights were triangulated with secondary sources such as peer-reviewed clinical studies, regulatory filings, and publicly available policy documents to validate trends and corroborate technical claims.

Analytical methods employed comparative scenario analysis to test strategic responses under varying regulatory and trade conditions, and cross-regional benchmarking to identify best practices in market access and supply chain design. Quality control measures included source verification, expert peer review, and sensitivity checks to ensure findings are robust and actionable. Throughout, emphasis was placed on practical implications for product development, commercial strategy, and operational execution.

A concise concluding synthesis that reinforces strategic priorities for converting technological advances into clinical adoption and sustainable commercial success

In summary, the bio-implant sector sits at the intersection of rapid technological progress and heightened operational complexity, demanding integrated strategies that marry innovation with pragmatic execution. Stakeholders who align platform design, materials expertise, and robust real-world evidence with resilient supply chains and regionally tailored market access plans are best positioned to convert scientific advances into durable commercial success. Moreover, the evolving tariff and regulatory environment underscores the need for flexible manufacturing and sourcing strategies that protect margins without sacrificing clinical quality.

Looking ahead, organizations that proactively invest in clinician partnerships, post-market data systems, and digital adjuncts will not only enhance patient outcomes but also strengthen payer conversations and long-term viability. The path forward requires disciplined prioritization, cross-functional coordination, and a willingness to adapt business models to new evidence and geopolitical realities. By doing so, companies can capture emerging opportunities while managing the risks inherent in a rapidly changing global healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-implant Market, by Product Type

  • 8.1. Cardiovascular Implants
    • 8.1.1. Artificial Heart Valves
    • 8.1.2. Pacemakers
    • 8.1.3. Stents
    • 8.1.4. Vascular Grafts
  • 8.2. Dental Implants
    • 8.2.1. Endosseous Implants
    • 8.2.2. Subperiosteal Implants
    • 8.2.3. Transosteal Implants
  • 8.3. Neurological Implants
    • 8.3.1. Deep Brain Stimulators
    • 8.3.2. Neuroprosthetics
    • 8.3.3. Spinal Cord Stimulators
  • 8.4. Ophthalmic Implants
    • 8.4.1. Corneal Implants
    • 8.4.2. Intraocular Lenses
    • 8.4.3. Retinal Implants
  • 8.5. Orthopedic Implants
    • 8.5.1. Hip Implants
      • 8.5.1.1. Hip Resurfacing
      • 8.5.1.2. Total Hip Replacement
    • 8.5.2. Knee Implants
      • 8.5.2.1. Partial Knee Replacement
      • 8.5.2.2. Total Knee Replacement
    • 8.5.3. Shoulder Implants
    • 8.5.4. Spinal Implants

9. Bio-implant Market, by Material

  • 9.1. Ceramic
  • 9.2. Composite
  • 9.3. Polymer
    • 9.3.1. Biodegradable Polymers
    • 9.3.2. Uhmwpe
  • 9.4. Titanium

10. Bio-implant Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Bio-implant Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Bio-implant Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bio-implant Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bio-implant Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Bio-implant Market

16. China Bio-implant Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. BioHorizons
  • 17.7. Dentsply Sirona Inc
  • 17.8. HIOSSEN
  • 17.9. Institut Straumann AG
  • 17.10. MEGA'GEN IMPLANT CO.,LTD.
  • 17.11. Nobel Biocare Services AG
  • 17.12. NuVasive, Inc.
  • 17.13. OSSTEM IMPLANT CO., LTD.
  • 17.14. Stryker Corporation
  • 17.15. Zimmer Biomet Holdings, Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIO-IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. GCC BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. GCC BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 251. GCC BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 254. GCC BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 255. GCC BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 257. GCC BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. GCC BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. G7 BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 287. G7 BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. G7 BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 291. G7 BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 292. G7 BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 295. G7 BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 296. G7 BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 297. G7 BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. G7 BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. NATO BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 300. NATO BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. NATO BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 305. NATO BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 306. NATO BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 307. NATO BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 308. NATO BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 309. NATO BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 310. NATO BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. NATO BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 338. CHINA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)